The Selective Social Attention task in children with autism spectrum disorder: Results from the Autism Biomarkers Consortium for Clinical Trials (ABC-CT) feasibility study
Frederick Shic,Erin C Barney,Adam J Naples,Kelsey J Dommer,Shou An Chang,Beibin Li,Takumi McAllister,Adham Atyabi,Quan Wang,Raphael Bernier,Geraldine Dawson,James Dziura,Susan Faja,Shafali Spurling Jeste,Michael Murias,Scott P Johnson,Maura Sabatos-DeVito,Gerhard Helleman,Damla Senturk,Catherine A Sugar,Sara Jane Webb,James C McPartland,Katarzyna Chawarska,Autism Biomarkers Consortium for Clinical Trials
DOI: https://doi.org/10.1002/aur.3026
Abstract:The Selective Social Attention (SSA) task is a brief eye-tracking task involving experimental conditions varying along socio-communicative axes. Traditionally the SSA has been used to probe socially-specific attentional patterns in infants and toddlers who develop autism spectrum disorder (ASD). This current work extends these findings to preschool and school-age children. Children 4- to 12-years-old with ASD (N = 23) and a typically-developing comparison group (TD; N = 25) completed the SSA task as well as standardized clinical assessments. Linear mixed models examined group and condition effects on two outcome variables: percent of time spent looking at the scene relative to scene presentation time (%Valid), and percent of time looking at the face relative to time spent looking at the scene (%Face). Age and IQ were included as covariates. Outcome variables' relationships to clinical data were assessed via correlation analysis. The ASD group, compared to the TD group, looked less at the scene and focused less on the actress' face during the most socially-engaging experimental conditions. Additionally, within the ASD group, %Face negatively correlated with SRS total T-scores with a particularly strong negative correlation with the Autistic Mannerism subscale T-score. These results highlight the extensibility of the SSA to older children with ASD, including replication of between-group differences previously seen in infants and toddlers, as well as its ability to capture meaningful clinical variation within the autism spectrum across a wide developmental span inclusive of preschool and school-aged children. The properties suggest that the SSA may have broad potential as a biomarker for ASD.